Marvin Whiteley

Marvin Whiteley is an American microbiologist and professor at the Georgia Institute of Technology who studies bacterial cell-cell communication and biofilm formation.^[1] Whiteley is also a Georgia Research Alliance Eminent Scholar^[2] and co-director of the Emory-Children's Cystic Fibrosis Center in Atlanta.^[3] His research is focused on how host-associated bacterial communities behave and cause disease, and his work in this area led him to co-found the biotechnology company SynthBiome^[4] to develop advanced infection model systems. Whiteley is a Fellow of the American Academy of Microbiology^[5]

Early life and education

Marvin Whiteley graduated from Belton High School (Texas) then earned his Bachelor of Science degree in zoology from the University of Texas at Austin in 1995. He went on to receive a Master of Science in biology from Southwest Texas State University (now Texas State University) in 1997.^[6] Whiteley completed his Ph.D. in microbiology at the University of Iowa in 2001. His doctoral research, conducted under microbiologist E. P. Greenberg, focused on quorum sensing and biofilm development in the bacterium Pseudomonas aeruginosa.^[7]

Career

In 2002, Whiteley joined the faculty at the University of Oklahoma as an assistant professor of microbiology. In 2006, Whiteley moved to the University of Texas at Austin to join the faculty of Molecular Genetics and Microbiology. He served as an assistant professor from 2006 to 2009 and was promoted to associate professor in 2009. He attained the rank of full professor by 2013 was appointed the inaugural Director of UT Austin's John Ring LaMontagne Center for Infectious Disease.^[8] During his tenure at UT Austin, Whiteley also held endowed positions as a fellow of the John Ring LaMontagne Chair in Infectious Diseases and Global Health (2013–2015) and the Mary M. Betzner Morrow Centennial Chair in Microbiology (2015–2017).^[9]

In 2017, Whiteley joined the Georgia Institute of Technology. He was recruited as the Bennie H. & Nelson D. Abell Chair in Molecular and Cellular Biology and as a Georgia Research Alliance Eminent Scholar at Georgia Tech.^[1] Whiteley founded and served as co-director of the Center for Microbial Dynamics and Infection at Georgia Tech,^[10] and continues to serve as co-director of the Emory-Children's Cystic Fibrosis Center (CF@LANTA) in Atlanta.^[3] In 2025, Whiteley was named Editor-in-Chief of mBio.^[11]

Whiteley has served on the editorial boards of the ASM journals Applied and Environmental Microbiology, Journal of Bacteriology, Infection and Immunity, and mBio.^[1]

Research contributions

Whiteley's research centers on bacterial social behavior and inter-microbe communication during chronic infection. Early work from his lab demonstrated that the pathogen Pseudomonas aeruginosa packages its quorum-sensing signal Pseudomonas quinolone signal (PQS) into outer membrane vesicles (OMVs) to disseminate this molecule among cells.^[12] Removing these OMVs halts PQS-based cell–cell communication, highlighting their role in coordinating group behavior.^[12] Whiteley also uncovered a biogenesis mechanism of OMVs, showing that PQS inserts into the outer membrane and induces curvature by expanding the outer lipid leaflet (a "bilayer-couple" model).^[13] This work suggested a general physical mechanism for OMV formation in Gram-negative bacteria, linking chemical signaling to membrane remodeling.^[13]

Whiteley research in oral biofilms showed that when the pathogen Aggregatibacter actinomycetemcomitans grows with streptococcal species (e.g. Streptococcus gordonii), it senses hydrogen peroxide produced by the streptococci and activates a defensive program, including upregulation of a complement-resistance protein, to withstand host immune attack.^[14] In respiratory and wound infections, Whiteley found that P. aeruginosa can detect peptidoglycan fragments shed by Gram-positive bacteria like Staphylococcus aureus, which triggers P. aeruginosa to produce lytic enzymes and toxins that enhance its virulence and suppress the neighboring Gram-positive population.^[15] These studies demonstrated that interspecies signals – from bacterial metabolites to fungal toxins – can alter bacterial behavior and virulence in mixed communities.^[16]

He has highlighted that up to 80% of bacteria in chronic infections exist in spatially structured communities, where micron-scale biogeography significantly shapes microbial interactions and pathogenic behavior. To investigate the importance of this microbiogeography in chronic infections, Whiteley and his collaborator Dr. Jason Shear pioneered the use of microfabricated "bacterial lobster traps" – picoliter-sized porous cavities that confine a small number of cells – to study dense aggregates of biofilm bacteria in controlled spatial arrangements.^[17] Using these traps, their teams showed that even clusters of ~150 bacteria can develop biofilm-like traits, such as heightened antibiotic tolerance and quorum-sensing activity, despite the low cell numbers.^[17][18] Whiteley developed a quantitative framework for evaluating how accurately laboratory infection models reproduce in vivo conditions.^[19] Applying this framework to P. aeruginosa lung infections in cystic fibrosis, his team identified which models best recapitulated the pathogen's in vivo physiology. Turner and Whiteley established a defined synthetic cystic fibrosis sputum medium (SCFM2) that closely mimics the chemical environment of CF sputum, yielding virtually identical bacterial fitness requirements to those observed in patient samples.^[20]

Honors

• Merck Irving S. Sigal Memorial Award (2008)^[21]
• Elected Fellow of the American Academy of Microbiology (2014)^[5]
• D.C. White award for Interdisciplinary Research, American Society for Microbiology (2026)^[22]

References

External links

• Whiteley Lab Website
• Georgia Tech Faculty Profile